Atria Wealth Solutions Inc. Grows Stock Position in The Procter & Gamble Company (NYSE:PG)

Atria Wealth Solutions Inc. raised its holdings in The Procter & Gamble Company (NYSE:PGFree Report) by 2.0% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 155,503 shares of the company’s stock after acquiring an additional 3,035 shares during the quarter. Atria Wealth Solutions Inc.’s holdings in Procter & Gamble were worth $22,787,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently bought and sold shares of PG. Wyrmwood Management LLC bought a new position in Procter & Gamble in the 4th quarter valued at $29,000. Naples Money Management LLC bought a new position in shares of Procter & Gamble during the 4th quarter worth $29,000. Criterion Capital Advisors LLC bought a new position in shares of Procter & Gamble during the 4th quarter worth $33,000. Mendota Financial Group LLC lifted its stake in shares of Procter & Gamble by 636.6% during the 4th quarter. Mendota Financial Group LLC now owns 302 shares of the company’s stock worth $44,000 after purchasing an additional 261 shares during the last quarter. Finally, Morton Brown Family Wealth LLC lifted its stake in shares of Procter & Gamble by 206.6% during the 4th quarter. Morton Brown Family Wealth LLC now owns 417 shares of the company’s stock worth $61,000 after purchasing an additional 281 shares during the last quarter. Institutional investors own 65.77% of the company’s stock.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, CEO R. Alexandra Keith sold 855 shares of Procter & Gamble stock in a transaction on Monday, April 22nd. The stock was sold at an average price of $158.50, for a total value of $135,517.50. Following the sale, the chief executive officer now owns 4,004 shares in the company, valued at $634,634. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, CEO R. Alexandra Keith sold 855 shares of Procter & Gamble stock in a transaction on Monday, April 22nd. The stock was sold at an average price of $158.50, for a total value of $135,517.50. Following the completion of the sale, the chief executive officer now directly owns 4,004 shares of the company’s stock, valued at $634,634. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Gary A. Coombe sold 22,000 shares of the company’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $161.32, for a total value of $3,549,040.00. Following the sale, the chief executive officer now owns 36,845 shares in the company, valued at approximately $5,943,835.40. The disclosure for this sale can be found here. Insiders have sold 103,771 shares of company stock worth $16,292,467 over the last quarter. 0.17% of the stock is currently owned by company insiders.

Procter & Gamble Trading Up 0.7 %

Procter & Gamble stock traded up $1.08 during trading on Wednesday, reaching $162.58. 7,216,558 shares of the company were exchanged, compared to its average volume of 6,971,658. The Procter & Gamble Company has a 52-week low of $141.45 and a 52-week high of $163.14. The company has a market capitalization of $383.71 billion, a P/E ratio of 26.57, a PEG ratio of 3.23 and a beta of 0.44. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.69 and a quick ratio of 0.48. The stock’s 50 day simple moving average is $159.46 and its two-hundred day simple moving average is $153.32.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings data on Friday, April 19th. The company reported $1.52 EPS for the quarter, topping analysts’ consensus estimates of $1.42 by $0.10. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The firm had revenue of $20.20 billion for the quarter, compared to the consensus estimate of $20.43 billion. During the same quarter last year, the business posted $1.37 earnings per share. The firm’s revenue was up .6% compared to the same quarter last year. On average, equities research analysts expect that The Procter & Gamble Company will post 6.54 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be given a dividend of $1.0065 per share. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.94. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.48%. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.85%.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the company. StockNews.com cut Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, February 29th. Barclays raised their target price on Procter & Gamble from $168.00 to $170.00 and gave the stock an “overweight” rating in a report on Tuesday. Royal Bank of Canada raised their target price on Procter & Gamble from $156.00 to $157.00 and gave the stock a “sector perform” rating in a report on Wednesday, January 24th. UBS Group raised their target price on Procter & Gamble from $172.00 to $178.00 and gave the stock a “buy” rating in a report on Wednesday, January 24th. Finally, Wells Fargo & Company raised their target price on Procter & Gamble from $162.00 to $170.00 and gave the stock an “overweight” rating in a report on Wednesday, January 24th. Seven research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat, Procter & Gamble presently has a consensus rating of “Moderate Buy” and an average price target of $168.88.

Check Out Our Latest Stock Report on Procter & Gamble

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Stories

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.